First Time Loading...

Longeveron Inc
NASDAQ:LGVN

Watchlist Manager
Longeveron Inc Logo
Longeveron Inc
NASDAQ:LGVN
Watchlist
Price: 1.82 USD -2.67%
Updated: Apr 24, 2024

Intrinsic Value

Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. [ Read More ]

The intrinsic value of one LGVN stock under the Base Case scenario is 2.2 USD. Compared to the current market price of 1.82 USD, Longeveron Inc is Undervalued by 17%.

Key Points:
LGVN Intrinsic Value
Base Case
2.2 USD
Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Longeveron Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LGVN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Longeveron Inc

Provide an overview of the primary business activities
of Longeveron Inc.

What unique competitive advantages
does Longeveron Inc hold over its rivals?

What risks and challenges
does Longeveron Inc face in the near future?

Has there been any significant insider trading activity
in Longeveron Inc recently?

Summarize the latest earnings call
of Longeveron Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Longeveron Inc.

Provide P/S
for Longeveron Inc.

Provide P/E
for Longeveron Inc.

Provide P/OCF
for Longeveron Inc.

Provide P/FCFE
for Longeveron Inc.

Provide P/B
for Longeveron Inc.

Provide EV/S
for Longeveron Inc.

Provide EV/GP
for Longeveron Inc.

Provide EV/EBITDA
for Longeveron Inc.

Provide EV/EBIT
for Longeveron Inc.

Provide EV/OCF
for Longeveron Inc.

Provide EV/FCFF
for Longeveron Inc.

Provide EV/IC
for Longeveron Inc.

Show me price targets
for Longeveron Inc made by professional analysts.

What are the Revenue projections
for Longeveron Inc?

How accurate were the past Revenue estimates
for Longeveron Inc?

What are the Net Income projections
for Longeveron Inc?

How accurate were the past Net Income estimates
for Longeveron Inc?

What are the EPS projections
for Longeveron Inc?

How accurate were the past EPS estimates
for Longeveron Inc?

What are the EBIT projections
for Longeveron Inc?

How accurate were the past EBIT estimates
for Longeveron Inc?

Compare the revenue forecasts
for Longeveron Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Longeveron Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Longeveron Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Longeveron Inc compared to its peers.

Compare the P/E ratios
of Longeveron Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Longeveron Inc with its peers.

Analyze the financial leverage
of Longeveron Inc compared to its main competitors.

Show all profitability ratios
for Longeveron Inc.

Provide ROE
for Longeveron Inc.

Provide ROA
for Longeveron Inc.

Provide ROIC
for Longeveron Inc.

Provide ROCE
for Longeveron Inc.

Provide Gross Margin
for Longeveron Inc.

Provide Operating Margin
for Longeveron Inc.

Provide Net Margin
for Longeveron Inc.

Provide FCF Margin
for Longeveron Inc.

Show all solvency ratios
for Longeveron Inc.

Provide D/E Ratio
for Longeveron Inc.

Provide D/A Ratio
for Longeveron Inc.

Provide Interest Coverage Ratio
for Longeveron Inc.

Provide Altman Z-Score Ratio
for Longeveron Inc.

Provide Quick Ratio
for Longeveron Inc.

Provide Current Ratio
for Longeveron Inc.

Provide Cash Ratio
for Longeveron Inc.

What is the historical Revenue growth
over the last 5 years for Longeveron Inc?

What is the historical Net Income growth
over the last 5 years for Longeveron Inc?

What is the current Free Cash Flow
of Longeveron Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Longeveron Inc.

Financials

Balance Sheet Decomposition
Longeveron Inc

Current Assets 5.8m
Cash & Short-Term Investments 5.4m
Receivables 111k
Other Current Assets 376k
Non-Current Assets 6.2m
PP&E 3.8m
Intangibles 2.3m
Other Non-Current Assets 193k
Current Liabilities 3.9m
Accounts Payable 638k
Accrued Liabilities 2.7m
Other Current Liabilities 506k
Non-Current Liabilities 1.4m
Other Non-Current Liabilities 1.4m
Efficiency

Earnings Waterfall
Longeveron Inc

Revenue
709k USD
Cost of Revenue
-488k USD
Gross Profit
221k USD
Operating Expenses
-21.3m USD
Operating Income
-21m USD
Other Expenses
-1.2m USD
Net Income
-22.2m USD

Free Cash Flow Analysis
Longeveron Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

LGVN Profitability Score
Profitability Due Diligence

Longeveron Inc's profitability score is 10/100. The higher the profitability score, the more profitable the company is.

10/100
Profitability
Score

Longeveron Inc's profitability score is 10/100. The higher the profitability score, the more profitable the company is.

LGVN Solvency Score
Solvency Due Diligence

Longeveron Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
51/100
Solvency
Score

Longeveron Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LGVN Price Targets Summary
Longeveron Inc

There are no price targets for LGVN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

LGVN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

LGVN Price
Longeveron Inc

1M 1M
-55%
6M 6M
-91%
1Y 1Y
-94%
3Y 3Y
-97%
5Y 5Y
-98%
10Y 10Y
-98%
Annual Price Range
1.82
52w Low
1.69
52w High
40
Price Metrics
Average Annual Return -4.49%
Standard Deviation of Annual Returns 95.66%
Max Drawdown -100%
Shares Statistics
Market Capitalization 4.6m USD
Shares Outstanding 2 510 000
Percentage of Shares Shorted 3.01%

LGVN Return Decomposition
Main factors of price return

What is price return decomposition?

LGVN News

Other Videos

Company Profile

Longeveron Inc Logo
Longeveron Inc

Country

United States of America

Industry

Biotechnology

Market Cap

4.6m USD

Dividend Yield

0%

Description

Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. The company is headquartered in Miami, Florida and currently employs 18 full-time employees. The company went IPO on 2021-02-12. The firm's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The company is sponsoring phase I and II clinical trials in various indications, such as aging frailty, Alzheimer's disease (AD), metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). The company is evaluating Lomecel-B as a therapy for aging frailty and is being designed to reduce inflammation associated with aging frailty and to promote an anti-inflammatory state by releasing anti-inflammatory molecules, which can promote physiological restoration to a more normal state. The firm has completed two multicenter trials in the United States for aging frailty.

Contact

FLORIDA
Miami
1951 NW 7th Ave Ste 520
+13053027158.0
https://www.longeveron.com/

IPO

2021-02-12

Employees

18

Officers

Co-Founder, Chief Science Officer & Chairman
Dr. Joshua Michael Hare FACC, M.D.
CEO & Director
Mr. Mohamed Wa'el Ahmed Hashad
Executive VP & CFO
Ms. Lisa A. Locklear M.B.A.
International Executive Director, General Counsel & Secretary
Mr. Paul T. Lehr J.D.
Senior Vice President of Strategic Collaborations & Scientific Affairs
Dr. Dan Gincel Ph.D.
Chief Medical Officer
Dr. Nataliya Agafanova M.D.
Show More
VP & Corporate Controller
Ms. Elly Ryu
Show Less

See Also

Discover More
What is the Intrinsic Value of one LGVN stock?

The intrinsic value of one LGVN stock under the Base Case scenario is 2.2 USD.

Is LGVN stock undervalued or overvalued?

Compared to the current market price of 1.82 USD, Longeveron Inc is Undervalued by 17%.